1. |
Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. N Engl J Med, 2018, 378(19): 1811-1823.
|
2. |
Chambers RC, Mercer PF. Mechanisms of alveolar epithelial injury, repair, and fibrosis. Ann Am Thorac Soc, 2015, 12: S16-S20.
|
3. |
Hutchinson JP, McKeever TM, Fogarty AW, et al. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century. Ann Am Thorac Soc, 2014, 11: 1176-1185.
|
4. |
Raghu G, Rochwerg B, Zhang Y, et al. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med, 2015, 192(2): e3-e19.
|
5. |
Selman M, King TE, Pardo A, et al. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med, 2001, 134(2): 136-151.
|
6. |
Harari S, Caminati A. IPF: new insight on pathogenesis and treatment. Allergy, 2010, 65(5): 537-553.
|
7. |
Leslie KO. Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. Arch Pathol Lab Med, 2012, 136(6): 591-600.
|
8. |
Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med, 2011, 208(7): 1339-1350.
|
9. |
Grammatikakis I, Panda AC, Abdelmohsen K, et al. Long noncoding RNAs (lncRNAs) and the molecular hallmarks of aging. Aging (Albany NY), 2014, 6(12): 992-1009.
|
10. |
Pandit KV, Milosevic J, Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res, 2011, 157(4): 191-199.
|
11. |
Emblom-Callahan MC, Chhina MK, Shlobin OA, et al. Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis. Genomics, 2010, 96(3): 134-145.
|
12. |
Kass DJ, Kaminski N. Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes. Clin Transl Sci, 2011, 4(5): 372-379.
|
13. |
Meltzer EB, Barry WT, D'Amico TA, et al. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. BMC Med Genomics, 2011, 4: 70.
|
14. |
Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res, 2013, 41: D991-D995.
|
15. |
Pardo A, Gibson K, Cisneros J, et al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med, 2005, 2(9): e251.
|
16. |
Wang XM, Zhang Y, Kim HP, et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med, 2006, 203(13): 2895-2906.
|
17. |
Peng R, Sridhar S, Tyagi G, et al. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease. PLoS ONE, 2013, 8(4): e59348.
|
18. |
Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res, 2015, 43(7): e47.
|
19. |
Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci, 1998, 95(25): 14863-14868.
|
20. |
Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res, 2009, 37(1): 1-13.
|
21. |
Harris MA, Clark J, Ireland A, et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res, 2004, 32: D258-261.
|
22. |
Kanehisa M, Sato Y, Kawashima M, et al. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res, 2016, 44(D1): D457-D462.
|
23. |
Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res, 2015, 43: D447-D452.
|
24. |
Smoot ME, Ono K, Ruscheinski J, et al. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics, 2011, 27(3): 431-432.
|
25. |
Bandettini WP, Kellman P, Mancini C, et al. MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study. J Cardiovasc Magn Reson, 2012, 14: 83.
|
26. |
Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics, 2009, 25(8): 1091-1093.
|
27. |
Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics, 2005, 21(16): 3448-3449.
|
28. |
中华医学会呼吸病学分会间质性肺疾病学组. 特发性肺纤维化诊断和治疗中国专家共识. 中华结核和呼吸杂志, 2016, 39(6): 427-432.
|
29. |
Gong C, Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature, 2011, 470(7333): 284-288.
|
30. |
Kretz M, Siprashvili Z, Chu C, et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature, 2013, 493(7431): 231-235.
|
31. |
Natoli G, Andrau JC. Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet, 2012, 46: 1-19.
|
32. |
Zong X, Tripathi V, Prasanth KV. RNA splicing control: yet another gene regulatory role for long nuclear noncoding RNAs. RNA Biol, 2011, 8(6): 968-977.
|
33. |
Sgalla G, Iovene B, Calvello M, et al. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res, 2018, 19(1): 32.
|
34. |
Li Y, Jiang D, Liang J, et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J Exp Med, 2011, 208(7): 1459-1471.
|
35. |
Hecker L, Jagirdar R, Jin T, et al. Reversible differentiation of myofibroblasts by MyoD. Exp Cell Res, 2011, 317(13): 1914-1921.
|
36. |
White ES, Thannickal VJ, Carskadon SL, et al. Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med, 2003, 168(4): 436-442.
|
37. |
Li Y, Bao C, Gu S, et al. Associations between novel genetic variants in the promoter region of and risk of colorectal cancer. Oncotarget, 2017, 8(54): 92604-92614.
|
38. |
Li Z, Ma Z, Xu X. Long non-coding RNA MALAT1 correlates with cell viability and mobility by targeting miR-22-3p in renal cell carcinoma via the PI3K/Akt pathway. Oncol Rep, 2019, 41(2): 1113-1121.
|
39. |
Lin LP, Niu GH, Zhang XQ. Influence of lncRNA MALAT1 on septic lung injury in mice through p38 MAPK/p65 NF-κB pathway. Eur Rev Med Pharmacol Sci, 2019, 23(3): 1296-1304.
|
40. |
Chen J, Wang S, Yu W, et al. MALAT1/miR-144/Brg1: a potential regulated axis of inflammation in myocardial ischemia-reperfusion injury. Int J Cardiol, 2019, 283: 151.
|
41. |
Tian H, Wu M, Zhou P, et al. The long non-coding RNA MALAT1 is increased in renal ischemia-reperfusion injury and inhibits hypoxia-induced inflammation. Ren Fail, 2018, 40(1): 527-533.
|
42. |
Huang S, Zhang L, Song J, et al. Long noncoding RNA MALAT1 mediates cardiac fibrosis in experimental postinfarct myocardium mice model. J Cell Physiol, 2019, 234(3): 2997-3006.
|
43. |
Wu Y, Liu X, Zhou Q, et al. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion. Toxicol Appl Pharmacol, 2015, 289(2): 163-176.
|
44. |
Yan W, Wu Q, Yao W, et al. MiR-503 modulates epithelial-mesenchymal transition in silica-induced pulmonary fibrosis by targeting PI3K p85 and is sponged by lncRNA MALAT1. Sci Rep, 2017, 7(1): 11313.
|
45. |
Sheu CC, Chang WA, Tsai MJ, et al. Gene expression changes associated with nintedanib treatment in idiopathic pulmonary fibrosis fibroblasts: a next-generation sequencing and bioinformatics study. J Clin Med, 2019, 8(3): E308.
|
46. |
Suresh PS, Tsutsumi R, Venkatesh T. YBX1 at the crossroads of non-coding transcriptome, exosomal, and cytoplasmic granular signaling. Eur J Cell Biol, 2018, 97(3): 163-167.
|